U.S. advocates for homeless seek creative solutions as cities crack down on car-camping

U.S. drug stores say pharmacist work action had minimal impact

Medicaid ‘Unwinding’ Causes Chaos in Some States

Paxlovid safe, effective in pregnancy --study

A study based on 211 pregnant women given the antiviral drug nirmatrelvir and ritonavir (Paxlovid) during pregnancy for acute COVID-19 infections shows no increased risk of adverse events in the women or their babies and a reduced risk of complications called the maternal morbidity and mortality index (MMMI).

The findings, published today in Nature Medicine, suggest the drug is safe to use in pregnancy and is effective in reducing MMMI risk but not COVID-related hospitalizations.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Opinion: Why more vaccines are needed to counter future COVID waves

America Is Gambling With Another Low-Vax Winter - The Atlantic

Health misinformation and lack of confidence in vaccines continue to grow-- survey shows

The Top COVID-19 Hot Spots in the U.S.

Shortage of RSV drug prompts Children’s hospitals to prepare for surge in admissions

 

“Widespread access [to the new antibody drug] will take time across many sectors of the pediatric population and won’t have as great an impact on volumes this immediate respiratory season,” the Children’s Hospital Association said in a statement.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Data supports use of face masks to reduce COVID transmissions --detailed study, JAMA

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

COVID vaccinations saved estimated 2.4 million lives globally in first 8 months --study

New U.S. CDC campaign asks health care leaders to take responsibility for reducing burnout

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Problem: Unapproved stem-cell therapies are being marketed to people with long COVID

New research has identified 38 direct-to-consumer businesses marketing stem-cell treatments and exosome therapies for COVID-19 infections and, especially, long COVID, despite lacking approval by US Food and Drug Administration and other regulatory body in the United States. Descriptions of the businesses and an analysis of their marketing strategies are published in Stem Cell Reports.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Street medicine practioners now getting paid but want higher rates

Biden administration looks to avoid hiccups as COVID-19 antivirals shift to commercial market

Pages

Subscribe to New York RSS
howdy folks